PHI with Abdominal aortic aneurysm
How does this condition affect your private health insurance?
An abdominal aortic aneurysm (AAA) is a localized enlargement of the abdominal aorta, the main artery supplying blood to the body, to at least 1.5 times its normal diameter. Often asymptomatic, it is frequently discovered incidentally during imaging for other conditions. The primary concern is rupture, which is a life-threatening event leading to severe internal bleeding and high mortality. Risk factors include advanced age, male gender, smoking, hypertension, and a family history of AAA. Regular surveillance is crucial for smaller aneurysms, while larger or rapidly expanding ones typically require surgical or endovascular repair to prevent rupture.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Develops slowly over years; if ruptured, the acute event is critical and lasts hours.
Duration of Illness (Lifetime)
Chronic condition requiring lifelong monitoring or post-operative follow-up after repair.
Cost of Treatment (Initial)
Tens of thousands of US dollars (e.g., $20,000 - $60,000) for surgical or endovascular repair.
Cost of Treatment (Lifetime)
Ranges from thousands for lifelong surveillance to tens of thousands for initial repair and ongoing follow-up, potentially higher with re-interventions.
Mortality Rate
Very high (80-90%) if ruptured and untreated; 1-5% for elective surgical repair.
Risk of Secondary Damages
High, especially if ruptured (e.g., organ damage, shock, death). Post-surgical complications like kidney injury, limb ischemia, or endoleaks are also significant.
Probability of Full Recovery
Good after successful elective repair, though lifelong follow-up is necessary. Significantly lower after a ruptured aneurysm due to critical illness and potential organ damage.
Underlying Disease Risk
Very high, commonly associated with atherosclerosis, hypertension, coronary artery disease, peripheral artery disease, and chronic obstructive pulmonary disease.